Such hypothesis is consistent with experimental evidences showing abnormal expression of p53 isoforms in head and neck, acute myeloid leukaemia (AML) and breast tumours (Bourdon et al, 2005; Anensen et al, 2006; Boldrup et al, 2007). The gene discussed is TP53; the disease is breast neoplasm.